- Home
- LPTX vs PRPL Comparison
LPTX vs PRPL Comparison
Compare LPTX & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- PRPL
- Stock Information
- Founded
- LPTX 2011
- PRPL 2010
- Country
- LPTX United States
- PRPL United States
- Employees
- LPTX N/A
- PRPL N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- PRPL Home Furnishings
- Sector
- LPTX Health Care
- PRPL Consumer Discretionary
- Exchange
- LPTX Nasdaq
- PRPL Nasdaq
- Market Cap
- LPTX 119.6M
- PRPL 96.8M
- IPO Year
- LPTX N/A
- PRPL N/A
- Fundamental
- Price
- LPTX $0.34
- PRPL $0.77
- Analyst Decision
- LPTX Buy
- PRPL Hold
- Analyst Count
- LPTX 2
- PRPL 2
- Target Price
- LPTX $8.00
- PRPL $1.25
- AVG Volume (30 Days)
- LPTX 5.9M
- PRPL 1.4M
- Earning Date
- LPTX 03-26-2025
- PRPL 05-06-2025
- Dividend Yield
- LPTX N/A
- PRPL N/A
- EPS Growth
- LPTX N/A
- PRPL N/A
- EPS
- LPTX N/A
- PRPL N/A
- Revenue
- LPTX N/A
- PRPL $487,877,000.00
- Revenue This Year
- LPTX N/A
- PRPL N/A
- Revenue Next Year
- LPTX N/A
- PRPL $5.62
- P/E Ratio
- LPTX N/A
- PRPL N/A
- Revenue Growth
- LPTX N/A
- PRPL N/A
- 52 Week Low
- LPTX $0.28
- PRPL $0.65
- 52 Week High
- LPTX $4.79
- PRPL $2.12
- Technical
- Relative Strength Index (RSI)
- LPTX 33.17
- PRPL 44.03
- Support Level
- LPTX $0.28
- PRPL $0.71
- Resistance Level
- LPTX $0.65
- PRPL $0.84
- Average True Range (ATR)
- LPTX 0.05
- PRPL 0.09
- MACD
- LPTX 0.02
- PRPL 0.00
- Stochastic Oscillator
- LPTX 16.22
- PRPL 18.67
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.